Literature DB >> 19615

Rate and proposed mechanism of anhydrotetracycline epimerization in acid solution.

T D Sokoloski, L A Mitscher, P H Yuen, J V Juvarkar, B Hoener.   

Abstract

The pathway through which the toxic tetracycline degradation product epianhydrotetracycline forms in solution was studied using high-performance liquid chromatography and circular dichroism, taking advantage of the large difference in ellipticity between the reactant and the product at 285 nm. The epimerization of anhydrotetracycline followed a reversible first-order process, and both analytical methods yielded the same rate constants. The rate constants indicate that anhydrotetracycline epimerization is faster than tetracycline epimerization. The equilibrium favored anhydrotetracycline, and the activation energies for the forward and reverse rates were almost the same as those for tetracycline epimerization. The epimerization was catalyzed by phosphate. Activation energies in 0.1 and 1 M phosphate were essentially the same. The equilibrium constants for both anhydrotetracycline and tetracycline favored the natural configuration rather than the epi series. Possible rationalization based on conformational and hydrogen bonding effects is presented.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 19615     DOI: 10.1002/jps.2600660829

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  2 in total

1.  Determination of the stability of tetracycline suspensions by high performance liquid chromatography.

Authors:  A Grobben-Verpoorten; K Dihuidi; E Roets; J Hoogmartens; H Vanderhaeghe
Journal:  Pharm Weekbl Sci       Date:  1985-06-21

2.  Tetracyclines as Inhibitors of Pre-microRNA Maturation: A Disconnection between RNA Binding and Inhibition.

Authors:  Amanda L Garner; Daniel A Lorenz; Jorge Sandoval; Erin E Gallagher; Samuel A Kerk; Tanpreet Kaur; Arya Menon
Journal:  ACS Med Chem Lett       Date:  2019-04-22       Impact factor: 4.345

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.